More on BLTE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (8/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Belite Bio (NQ:BLTE)
Delayed: 173.30 +0.73 (0.42%)
Prev. Close $172.57  
Open$171.56 
52 Wk High$ 
52 Wk Low$ 
Day High$177.93 
Day Low$168.21 
P/E N/A  
EPS$ 
Volume135,955 

Friends, Peers and Foes (?): VIOT, YRD, IH, LOT, COE (more...)

Mar 4, 2026 08:42 AM Mizuho Reiterates Outperform Rating on Belite Bio, Inc, ADR (BLTE): "very well positioned"
Mar 4, 2026 06:41 AM Belite Bio, Inc, ADR (BLTE) PT Raised to $200 at H.C. Wainwright
Mar 3, 2026 08:18 AM Belite Bio, Inc, ADR (BLTE) PT Raised to $217 at Benchmark Following Business Update
Mar 3, 2026 08:11 AM Belite Bio, Inc, ADR (BLTE) PT Raised to $201 at Morgan Stanley
Mar 3, 2026 07:44 AM Belite Bio, Inc, ADR (BLTE) PT Raised to $266 at Cantor Fitzgerald After Higher WAC Announced
Mar 2, 2026 04:27 PM Belite Bio (BLTE) Tops Q4 EPS by 15c
Mar 2, 2026 08:00 AM Belite Bio to Participate in the Leerink Global Healthcare Conference
Mar 2, 2026 06:10 AM Form 6-K BELITE BIO, INC For: Mar 02
Mar 2, 2026 06:00 AM Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Feb 23, 2026 08:00 AM Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
View All Articles

Entities mentioned with BLTE

View All Entities